MedTrace Logo

Evaluation of the Sarcopenia in Hepatobiliary Surgery

NCT03754452 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2024-01-11

No results posted yet for this study

Summary

The sarcopenia is defined as a loss of muscle mass and a loss of muscle function ( strength or performance). Some studies showed that the sarcopenia increase the postoperative complications and the overall survival in abdominal surgery. But the sarcopenia is not evaluated in the Hepatobiliary surgery. This prospective, monconcentrique study aim to evaluate the prevalence of sarcopenia, and its associated morbimortality in hepatobiliary surgery for malignant or benign tumors.

Conditions

  • Sarcopenia
  • Hepatobiliary Disease
  • Postoperative Complications
  • Surgery

Sponsors & Collaborators

  • University Hospital, Angers

    lead OTHER_GOV

Principal Investigators

  • Julien BARBIEUX, Dr · University Hospital, Angers

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-09
Primary Completion
2021-09-07
Completion
2021-09-07

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03754452 on ClinicalTrials.gov